(Q34714754)

4 August 2017

1 reference

title

High blood pressure in the geriatric population: treatment considerations (English)

1 reference

4 August 2017

Sander GE

1

1 reference

4 August 2017

1 July 2002

1 reference

The American Journal of Geriatric Cardiology

4 August 2017

1 reference

4 August 2017

11

1 reference

4 August 2017

4

1 reference

4 August 2017

223-232

1 reference

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

4 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Reduced β-adrenoceptor sensitivity in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Salt sensitivity and systemic hypertension in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Laragh's lessons in pathophysiology and clinical pearls for treating hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Efficacy of valsartan in patients aged > or =65 years with systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial. ACTION Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Nonsteroidal anti-inflammatory drugs and antihypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

The impact of nonsteroidal anti-inflammatory drugs on hypertension: alternative analgesics for patients at risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

The Natural History of Borderline Isolated Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00032.X

10.1111/J.1076-7460.2002.00032.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12091771